Universidad de Navarra
Organización
University of Sydney
Sídney, AustraliaPublicaciones en colaboración con investigadores/as de University of Sydney (84)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Combining diaries and accelerometers to explain change in physical activity during a lifestyle intervention for adults with prediabetes: A PREVIEW sub-study
PLoS ONE, Vol. 19, Núm. 3 March
-
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
The Lancet Oncology, Vol. 25, Núm. 8, pp. e374-e387
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
Hybrid Evaluation of a Lifestyle Change Program to Prevent the Development of Type 2 Diabetes Among Individuals With Prediabetes: Intended and Observed Changes in Intervening Mechanisms
Journal of primary care & community health, Vol. 15
-
Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries
British Journal of Surgery, Vol. 111, Núm. 1
-
Role of Eating Behavior and Stress in Maintenance of Dietary Changes During the PREVIEW Intervention
Journal of Nutrition Education and Behavior, Vol. 56, Núm. 5, pp. 276-286
-
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
-
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
Ophthalmology, Vol. 131, Núm. 8, pp. 914-926
-
Technical considerations for isolated limb perfusion: A consensus paper
European Journal of Surgical Oncology, Vol. 50, Núm. 6
-
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases
Matrix Biology, Vol. 132, pp. 1-9
2023
-
Associations of obesity phenotypes with weight change, cardiometabolic benefits, and type 2 diabetes incidence during a lifestyle intervention: results from the PREVIEW study
International Journal of Obesity, Vol. 47, Núm. 9, pp. 833-840
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
-
Differences between HbA1c and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia – The PREVIEW trial
Clinical Nutrition, Vol. 42, Núm. 5, pp. 636-643
-
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
The Lancet. Oncology, Vol. 24, Núm. 7, pp. e293-e311
-
Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients
Seminars in Hematology
-
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients
Seminars in Hematology
-
Socio-economic factors, mood, primary care utilization, and quality of life as predictors of intervention cessation and chronic stress in a type 2 diabetes prevention intervention (PREVIEW Study)
BMC Public Health, Vol. 23, Núm. 1
2022
-
Age- and sex-specific effects of a long-term lifestyle intervention on body weight and cardiometabolic health markers in adults with prediabetes: results from the diabetes prevention study PREVIEW
Diabetologia, Vol. 65, Núm. 8, pp. 1262-1277
-
Animal-based food choice and associations with long-term weight maintenance and metabolic health after a large and rapid weight loss: The PREVIEW study
Clinical Nutrition, Vol. 41, Núm. 4, pp. 817-828